期刊文献+

趋化因子受体CXCR4在非小细胞肺癌中的表达及其意义 被引量:5

Expression and Significance of CXCR4 Chemokine Receptor in Non Small Cell Lung Cancer
原文传递
导出
摘要 目的探讨CXCR4在肺癌组织中的表达及意义。方法应用免疫组织化学方法检测84例肺癌组织、20例正常肺组织中CXCR4的表达,其中84例肺癌中包括36例淋巴结转移。结果 CXCR4蛋白在肺正常组织表达较低,在84例肺癌组织中的阳性表达率高达60.7%(51/84)。CXCR4的表达与肺癌患者的年龄、性别无关,而与分化程度、TNM分期、病理类型和淋巴结转移有相关性。低分化组肺癌组织CXCR4阳性表达率(78.95%)明显高于高中分化组(45.65%)。临床Ⅰ、Ⅱ和Ⅲ期的肺癌组织CXCR4蛋白阳性表达率分别为50.81%和86.96%;伴淋巴结转移组肺癌CXCR4蛋白阳性表达率为77.78%,没有淋巴结转移组阳性表达率为47.92%;而病理类型中腺癌的阳性表达较高(86.36%)。结论肺癌组织中高表达的CXCR4很可能是促进肺癌侵袭和转移的一个重要分子。 Objective To investigate the expression of CXCR4 in human lung cancer tissue and its clinical significance. Methods CXCR4 expression was detected in normal lung tissues adjacent to cancer lesions of 20 patients, and lung cancer of 84 patients, including 36 metastatic lymph node specimens by immunohistochemistry staining. Results The positive expression rate of CXCR4 protein were 60.7% (51/84) in 84 lung cancer tissues, and expression of CXCR4 protein was low in normal lung tissues. CXCR4 expression was correlated with the differentiation, TNM stage, pathological type and metastasis of lymph node, but had no relationship with age and gender. There was significant difference between the well differentiated group(45.65% ) and the poor differentiated group(78.95% ) ,P 〈0.05 ,CXCR4 in the( I + II ) stage(50.81% ) was distinctly lower than that in the III stage( 86.96% ) ;the difference of positive rate of CXCR4 was significant between group with metastasis of lymph node and group without metastasis of lymph node,P 〈 0.05 ; CXCR4 expression was higher in adenocarcinoma( 86.36% ). Conclusion Upregulation of CXCR4 expression in lung cancer tissue probably played an important role in carcinogenesis and metastasis of lung caneer.
出处 《中华全科医学》 2012年第9期1335-1336,共2页 Chinese Journal of General Practice
基金 湖北省自然科学基金资助项目(201006809 2011CHB018)
关键词 非小细胞肺癌 CXCR4 Non small cell lung cancer CXCR4
  • 相关文献

参考文献10

  • 1王杰,欧周罗,邵志敏.CXCL12-CXCR4生物学轴与肿瘤转移[J].国外医学(肿瘤学分册),2004,31(5):326-330. 被引量:12
  • 2Stetler-Stevenson WG, Kleiner DE Jr. Molecular biology of cancer:In- vasion and metastasis [ M ]//DeVita VT Jr, Hellman S, Rosenberg SA, et al. Cancer: Principles and Practice of Oncology. Philadelphia, PA: Lippincott Williams & Wilkins,2001:123-136.
  • 3Juarez J, Bendall L, Bt'adstock K. Chemokine and their receptors as therapeutic targets: the role of the SDF-1/CXCR4 axis [ J ]. Curr Pharm Des,2004,10 ( 11 ) : 1245-1259.
  • 4Taichman RS, Cooper C, Keller ET, et al. Use of the stromal cell-de- rived factor-l/CXCR4 pathway in prostate cancer metastasis to bone [ J]. Cancer Res.2002.62(6) : 1832-1837.
  • 5Murphy PM. Chemokines and the molecular basis of CanCer metastasis [ J]. N Engl J Med,2001,345 ( 11 ) :833-835.
  • 6Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4[ J]. Semin Cancer Biol,2004,14(3) :171-179.
  • 7徐永,张素珍,黄培春,陈锦,蔡康荣.趋化因子受体CXCR4在鼻咽癌细胞中的表达[J].癌症,2004,23(2):136-140. 被引量:15
  • 8Su L,Zhang J,Xu H,et al. Differential expression of CXCR4 is associ- ated with the metastatic potential of human non-small cell lung cancer ceils[ J]. Clin Cancer Res ,2005,11 ( 23 ) :8273-8280.
  • 9Lapteva N,Yang AG, Sanders DE, et al. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth iIlvivo[ J]. CancerGcne Ther,2005,12( 1 ) :84-89.
  • 10王祖义,黎传奎,王萍,刘学刚,唐震,汪国文.非小细胞肺癌淋巴管生成的研究及意义[J].中华全科医学,2009,7(11):1148-1149. 被引量:1

二级参考文献51

  • 1王艳,朱波,叶明福,陈正堂.podoplanin在非小细胞肺癌组织中的表达及其与肿瘤淋巴转移的关系[J].重庆医学,2005,34(11):1664-1666. 被引量:11
  • 2黄俊辉,李洋,杨怀才,海健,胡铁辉.乳腺癌淋巴管生成与肿瘤转移的关系[J].中国肿瘤临床,2006,33(11):601-604. 被引量:12
  • 3Rivadeneira DE, Simmons RM, Christos P J, et al. Predictive factors associated with axillary lymph node metastasis in TIa and TIb breast carcinomas :analysis in more than 900 patients [ J ]. J Am Coll Surg, 2000,191 (1) :1-6.
  • 4Regnard JF, Santelmo N, Romdhani N, et al. Bronchioloalveolar lung carcinoma: results of surgical treatment and prognostic factors [ J ]. Chest, 1998, 114 ( 1 ) :45-50.
  • 5Fu XL,Zhu XZ, Shi DR, et al. Study of prognostic predictors for non- small cell lung cancer[J]. Lung Cancer, 1999,23(2) :143-152.
  • 6Cunnick GH ,Jiang WG, Gomez KF, et al. lymphangiogenesis quantification using quantitative PCR and breast cancer as a model [ J ]. Biochem Biophys Res Commuu,2001,288(4) :1043-1046.
  • 7Austrian Breast and Colorectal Cancer Study Group. Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer [J]. Ann Surg,2004,240(2) :306-312.
  • 8Beasley N J, Prevo R, Banerji S, et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer[ J]. Cancer Res, 2002,62(5) : 1315-1320.
  • 9Hall FT,Freeman JL,Asa SL,et al. Intratumoral Lymphatics and Lymph Node Metastasis in Papillary Thyroid Carcinoma[ J]. Archives of Otolaryngology-Head & Neck Surgery,2003,129(7) :716-719.
  • 10Persaud K, Tille JC, Liu M, et al. Involvement of the VEGF receptor 3 in tubularmorphogenesis demonstrated with a human antihuman VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C [ J ]. Cell Sci ,2004,117 ( 13 ) :2745-2756.

共引文献25

同被引文献42

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部